Phase II Trial of Trastuzumab and Docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma
Key publications on oral cancers
Chairpersons :
Anil D'Cruz, A. R. Fakih, Vivek Kaushal
Reviewer :
Rakesh Pinninti
Phase II Trial of Trastuzumab and Docetaxel in patients with human epidermal growth factor receptor 2-positive salivary duct carcinoma
Chairpersons :
Anil D'Cruz, A. R. Fakih, Vivek Kaushal
Reviewer :
Rakesh Pinninti